BioSpace News Archive

89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced it has received written guidance from the U.S. Food and Drug Administration (FDA) on the company’s design of its planned Phase 2b ENLIVEN trial evaluating BIO89-100

Blueprint Medicines Corporation (NASDAQ: BPMC), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Monday, April 12, 2021 to review new data for multiple research- and clinical-stage programs across its precision oncology and hematology portfolio.

Resonant Inc. (NASDAQ: RESN), a provider of radio frequency (RF) filter solutions developed on a robust intellectual property platform, designed to connect People and Things, has signed an extension to its licensing agreement with an existing Tier-1 Chinese foundry partner, providing prepaid royalties for multiple RF filter designs to address the China mobile handset market.

4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (“4Front” or the “Company”), a national multi-state cannabis operator and retailer, with a market advantage in mass-produced, low-cost quality branded cannabis products, today announces that its executive team will participate in the following conferences in April 2021:

Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its Executive Vice President and Chief Operating Officer, Michael Redman, will present at the annual Cell & Gene Meeting on the Mediterranean, which will take place virtually April 6-9, 2021.

Applied UV, Inc., an infection control technology company that applies the power of narrow-range ultraviolet light for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that Mike Riccio, CPA, is appointed Chief Financial Officer, effective April 5, 2021.

BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a leading pre-clinical-stage biotechnology company focused on harnessing elements of perinatal tissue for use in regenerative therapies, today reported financial results for the three and twelve months ended December 31, 2020.

AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today provided a business update.

Olive Union Raises $20M to Expand into Digital Hearing Therapeutics The global smart hearing aid startup is developing new digital therapies for tinnitus and overall hearing health.

BioMed Realty, a leading provider of real estate solutions for the life science and technology industries, has received approval from the City to expand its flagship Emeryville Center of Innovation campus.